Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats

Mesenchymal stem cells (MSCs) derived from bone marrow can secrete cytokines and growth factors and can transdifferentiate into liver cells. We transplanted polymeric membrane bioencapsulated MSCs into the spleens of 90% partial hepatectomized rats. This resulted in 91.6% recovery rates. This is com...

Full description

Saved in:
Bibliographic Details
Main Authors: Zun Chang Liu, Thomas Ming Swi Chang
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2012/697094
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549937363025920
author Zun Chang Liu
Thomas Ming Swi Chang
author_facet Zun Chang Liu
Thomas Ming Swi Chang
author_sort Zun Chang Liu
collection DOAJ
description Mesenchymal stem cells (MSCs) derived from bone marrow can secrete cytokines and growth factors and can transdifferentiate into liver cells. We transplanted polymeric membrane bioencapsulated MSCs into the spleens of 90% partial hepatectomized rats. This resulted in 91.6% recovery rates. This is compared to a recovery rate of 21.4% in the 90% hepatectomized rats and 25% in the 90% hepatectomized rats receiving intrasplenic transplantation of free MSCs. After 14 days, the remnant livers in the bioencapsulated MSCs group are not significantly different in weight when compared to the sham control group. From day 1 to day 3 after surgery, in the bioencapsulated MSCs group, the plasma HGF and IL-6 were significantly higher than those in the free MSCs group and control group (P<0.01); plasma TNF-α was significantly lower (P<0.001). We concluded that the intrasplenic transplantation of bioencapsulated MSCs significantly increases the recovery rates of 90% hepatectomized rats. It is likely that the initial effect is from proliver regeneration factors followed later by the transdifferentiated hepatocyte-like cells. However, histopathological analysis and hepatocyte proliferation study will be needed to better understand the regenerative mechanisms of this result. This study has implications in improving the survival and recovery of patients with very severe liver failure due to hepatitis, trauma, or extensive surgical resection.
format Article
id doaj-art-632aaefdb10c4ca7b28534ddd54ddb90
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-632aaefdb10c4ca7b28534ddd54ddb902025-02-03T06:08:09ZengWileyStem Cells International1687-966X1687-96782012-01-01201210.1155/2012/697094697094Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized RatsZun Chang Liu0Thomas Ming Swi Chang1Departments of Physiology, Medicine, and Biomedical Engineering, Artificial Cells and Organs Research Center, Faculty of Medicine, McGill University, 3655 Promenade Sir William Osler, Room 1004, Montreal, QC, H3G 1Y6, CanadaDepartments of Physiology, Medicine, and Biomedical Engineering, Artificial Cells and Organs Research Center, Faculty of Medicine, McGill University, 3655 Promenade Sir William Osler, Room 1004, Montreal, QC, H3G 1Y6, CanadaMesenchymal stem cells (MSCs) derived from bone marrow can secrete cytokines and growth factors and can transdifferentiate into liver cells. We transplanted polymeric membrane bioencapsulated MSCs into the spleens of 90% partial hepatectomized rats. This resulted in 91.6% recovery rates. This is compared to a recovery rate of 21.4% in the 90% hepatectomized rats and 25% in the 90% hepatectomized rats receiving intrasplenic transplantation of free MSCs. After 14 days, the remnant livers in the bioencapsulated MSCs group are not significantly different in weight when compared to the sham control group. From day 1 to day 3 after surgery, in the bioencapsulated MSCs group, the plasma HGF and IL-6 were significantly higher than those in the free MSCs group and control group (P<0.01); plasma TNF-α was significantly lower (P<0.001). We concluded that the intrasplenic transplantation of bioencapsulated MSCs significantly increases the recovery rates of 90% hepatectomized rats. It is likely that the initial effect is from proliver regeneration factors followed later by the transdifferentiated hepatocyte-like cells. However, histopathological analysis and hepatocyte proliferation study will be needed to better understand the regenerative mechanisms of this result. This study has implications in improving the survival and recovery of patients with very severe liver failure due to hepatitis, trauma, or extensive surgical resection.http://dx.doi.org/10.1155/2012/697094
spellingShingle Zun Chang Liu
Thomas Ming Swi Chang
Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats
Stem Cells International
title Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats
title_full Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats
title_fullStr Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats
title_full_unstemmed Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats
title_short Intrasplenic Transplantation of Bioencapsulated Mesenchymal Stem Cells Improves the Recovery Rates of 90% Partial Hepatectomized Rats
title_sort intrasplenic transplantation of bioencapsulated mesenchymal stem cells improves the recovery rates of 90 partial hepatectomized rats
url http://dx.doi.org/10.1155/2012/697094
work_keys_str_mv AT zunchangliu intrasplenictransplantationofbioencapsulatedmesenchymalstemcellsimprovestherecoveryratesof90partialhepatectomizedrats
AT thomasmingswichang intrasplenictransplantationofbioencapsulatedmesenchymalstemcellsimprovestherecoveryratesof90partialhepatectomizedrats